Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.

Abstract

No abstract available.

Authors
  • Akslen LA
  • Bielenberg DR
  • Blois A
  • Drapkin R
  • El Rayes T
  • Gravdal K
  • Hirsch MS
  • Liu JF
  • Mittal V
  • Palakurthi S
  • Wang S
  • Watnick RS
PubMed ID
Appears In